No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.
No article has been written about this topic yet.
Be the first one to add some text.
Loading AI-assisted edit mode...
Timeline
April 2019
SpringWorks Therapeutics raises a $125,000,000 series B round from ArrowMark Partners, Biotechnology Value Fund, Surveyor Capital, Samsara BioCapital, GlaxoSmithKline, Tavistock Group, HBM Healthcare Investments AG, OrbiMed, Pfizer Ventures, Laurion Capital Management and LifeArc.
September 2017
SpringWorks Therapeutics raises a $103,000,000 series A round from Bain Capital Double Impact, OrbiMed, Pfizer, Bain Capital Life Sciences and LifeArc.
Funding rounds
Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Series B round125,000,000
April 2019
HBM Healthcare Investments AG
Tavistock Group
Biotechnology Value Fund (BVF Partners)
Surveyor Capital
Samsara BioCapital
ArrowMark Partners
GlaxoSmithKline
Laurion Capital Management
OrbiMed
Pfizer Ventures
LifeArc
Series A round
Bain Capital Life Sciences
Bain Capital Double Impact
PfizerPeople
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Krystle Vermes
May 29, 2020
BioSpace
The data, which was presented at the American Society of Clinical Oncology annual meeting, looked into the use of ALLO-501 for relapsed/refractory non-Hodgkin lymphoma.
BioSpace
May 26, 2020
BioSpace
SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, announced the appointment of Julie Hambleton, M.D. to the Company's Board of Directors.
SpringWorks Therapeutics
Is a
CompanyCompany attributes
Industry
Biotechnology
Durham, North Carolina
Stamford, ConnecticutLegal name
SpringWorks Therapeutics, LLC
Crunchbase
Investors
Total funding amount (USD)
228,000,000
Other attributes
Headquarters
